CHDI has selected drug development company Evotec (Hamburg, Germany) as strategic drug discovery partner in the search for Huntington's Disease (HD) treatments.(Brief article)

CHDI has selected drug development company Evotec (Hamburg, Germany) as strategic drug discovery partner in the search for Huntington's Disease (HD) treatments. The agreement covers medicinal chemistry, assay development, medium-throughput screening and ultra-high-throughput screening, as well as library synthesis and management services. CHDI is …